(Press-News.org) Ovarian cancer cells can lock into survival mode and avoid being destroyed by chemotherapy, an international study reports.
Professor Sean Grimmond, from The University of Queensland's Institute for Molecular Bioscience, said ovarian cancer cells had at least four different ways to avoid being destroyed by platinum-based chemotherapy treatments.
"One way involves breaking and rearranging big groups of genes - the chromosomes," Professor Grimmond said.
"This is fundamentally different to other cancers where the disease is driven by smaller but more gradual changes to individual genes.
"It is essentially shattering big chunks of the cell's hard drive and moving them around, rather than just changing bits in the files."
The research used whole genome sequencing to analyse tumour DNA samples from 91 patients with high-grade serous ovarian cancer (HGSC).
HGSC is the most fatal form of ovarian cancer, a disease for which there are more than 1300 diagnoses in Australia each year.
Professor Grimmond said it was a recurrent form of cancer that often developed resistance to standard platinum-based chemotherapy treatments that aimed to damage tumour DNA beyond repair.
There have been no major changes in survival rates or treatments for HGSC patients in the past 30 years.
Professor Grimmond, now based at The University of Glasgow's Wolfson Wohl Cancer Research Centre, and Professor David Bowtell from Melbourne's Peter MacCallum Cancer Centre led the research team with Professor Anna deFazio from Sydney's Westmead Millennium Institute for Medical Research. They collaborated with a team of cancer researchers, including Dr Ann-Marie Patch from QIMR Berghofer Medical Research Institute, formerly from IMB, to interpret the sequencing results.
Professor Bowtell, Head of Peter Mac's Cancer Genomics Program and of the Australian Ovarian Cancer Study (AOCS) from which many of the patient samples were obtained, said until now there had been little information to guide clinicians when selecting a treatment for women whose cancer had returned.
"For decades clinicians around the world have watched HGSCs shrink under attack from chemotherapy before returning aggressively months or years later," he said.
"By completely sequencing the cancers, sampled at different stages of disease, for the first time we can map their evolution under the selective pressure of chemotherapy and begin work on better interventions."
Dr Patch, formerly from IMB and now at QIMR Berghofer's Medical Genomics Group, acknowledged the support of patients and their families who had participated in the study
"The brave patients allowed their tumour samples to be collected so that we can find out what happens to the cancer cells after treatment and will allow us to work towards better treatments for women in the future," she said.
Professor Grimmond said the research indicated a range of approaches would be needed to overcome resistance to treatment.
"We now know that not only are there many sub-types of this disease, but there are also different sub-types of resistant disease, which has huge implications for designing future treatments," he said.
"We really need to continue to write the atlas for this complex disease and get more sophisticated about the amount of drug we give, when we give it, and the types and combinations of treatments in relation to each patient's cancer."
The study's results are published today in Nature.
INFORMATION:
The study was supported by the National Health and Medical Research Council, Cancer Australia and World Wide Cancer Research (UK), and forms part of the International Cancer Genome Consortium.
Is it possible to tap into the signalling in the brain to figure out where you will go next? Hiroshi Ito, a researcher at the Kavli Institute for Systems Neuroscience at the Norwegian University of Science and Technology (NTNU), can now say yes. Ito has just published a description of how this happens in this week's edition of Nature.
Ito and his colleagues, including his supervisors, 2014 Nobel Laureates May-Britt and Edvard Moser, sampled a specific neural pathway to figure out if it is the location of the mechanism that enables animals to code their plan to get from ...
The latest generation of genomic testing offers a chance for significant improvements in patient care, disease prevention, and possibly even the cost-effectiveness of healthcare. A new report recommends that Congress act to incentivize the development of the massive data systems that doctors and regulators will need to make these tests safe and effective for patients.
A team of three leading researchers in law, bioethics, and medical genetics believes the solution lies in bolstering existing regulatory oversight with a systematic, ongoing program of postmarket data ...
A new study suggests that states may not save as much money as anticipated by eliminating adult dental coverage under Medicaid.
The study from University of Iowa researchers looked at California, which decided to end adult dental coverage under Medicaid in mid-2009. Some 3.5 million low-income adults in the Golden State lost dental benefits.
The researchers found those adults made more than 1,800 additional visits annually to hospital emergency departments for dental care after losing the benefit. In all, California spent $2.9 million each year in Medicaid costs for ...
Today's industrial robots are remarkably efficient -- as long as they're in a controlled environment where everything is exactly where they expect it to be.
But put them in an unfamiliar setting, where they have to think for themselves, and their efficiency plummets. And the difficulty of on-the-fly motion planning increases exponentially with the number of robots involved. For even a simple collaborative task, a team of, say, three autonomous robots might have to think for several hours to come up with a plan of attack.
This week, at the Institute for Electrical and ...
WINSTON-SALEM, N.C. - May 27, 2015 - Picture yourself in a medical office, anxiously awaiting your annual flu shot. The nurse casually states, "This won't hurt a bit." But when the needle pierces your skin it hurts, and it hurts a lot. Your expectations have been violated, and not in a good way.
In a study published in the early online edition of the journal PAIN, researchers at Wake Forest Baptist Medical Center have identified through imaging the part of the brain that is activated when a person expects one level of pain but experiences another.
"This finding gives ...
New models developed at the Masonic Cancer Center, University of Minnesota reveal the genes and pathways that, when altered, can cause osteosarcoma. The information could be used to better target treatments for the often-deadly type of cancer.
The new research is published in Nature Genetics.
"Human osteosarcoma tumors are so genetically disordered it is nearly impossible to utilize usual methods to identify the genes associated with them," said first author Branden Moriarty, Ph.D., researcher in the Masonic Cancer Center and the University of Minnesota Medical School's ...
ANN ARBOR--Economically vulnerable families are increasingly willing to take on debt to maintain a basic standard of living--a situation that can put them into a deep financial hole, according to a new University of Michigan study.
Poor families can find it challenging to stay on top of bills to keep the lights on, food on the table and a roof over their head--and they fall into debt, said Kristin Seefeldt, U-M assistant professor of social work and public policy.
"Unfortunately, once in debt, getting out was difficult," she said.
Trying to replace short-term losses ...
Using ever more energetic lasers, Lawrence Livermore researchers have produced a record high number of electron-positron pairs, opening exciting opportunities to study extreme astrophysical processes, such as black holes and gamma-ray bursts.
By performing experiments using three laser systems -- Titan at Lawrence Livermore, Omega-EP at the Laboratory for Laser Energetics, and Orion at Atomic Weapons Establishment (AWE) in the United Kingdom -- LLNL physicist Hui Chen and her colleagues created nearly a trillion positrons (also known as anti-matter particles). In previous ...
ANN ARBOR--For decades, scientists have known that ET-743, a compound extracted from a marine invertebrate called a mangrove tunicate, can kill cancer cells. The drug has been approved for use in patients in Europe and is in clinical trials in the U.S.
Scientists suspected the mangrove tunicate, which is a type of a sea squirt, doesn't actually make ET-743. But the precise origins of the drug, which is also known as trabectedin, were a mystery.
By analyzing the genome of the tunicate along with the microbes that live inside it using advanced sequencing techniques, researchers ...
WASHINGTON -- A national regulatory framework designed to prevent and limit indoor tanning is needed to alleviate the cancer burden and reduce the billions in financial costs from preventable skin cancer, say two Georgetown University public health experts.
In their "Viewpoint" published online today in JAMA, Darren Mays, PhD, MPH, and John Kraemer, JD, MPH, explore a regulatory opportunity--similar to the way toy safety standards were achieved--that could help drive strong, national policies regarding indoor tanning.
According to "The Surgeon General's Call to Action ...
